The largest community of pharma leaders

Be part of our community by subscribing to our newsletters! Follow the steps below.

1. Subscribe to our Announcement Newsletter. You will receive our news about what do you kneed to know about our work and the resources available for you. 

2. Choose your favorite writer. We constantly look for the top minds on the pharmaceutical marketing industry. You can subscribe to their article on their pages and receive every article on your inbox. 

3. Choose the Newsletter that better fits you needs. We recommend the Editor’s pick to receive everything you need to know in one weekly email. 

You can start here by subscribing to our main Newsletter

NEWSLETTER ANNOUCEMENTS




TPMG FEATURED WRITER NEWSLETTER




Secondary effects of COVID-19 on the healthcare system and...

A version of this article was previously published on Pharmaphorum. By now, your social media feeds are probably full...

“Go-to-Market”: Medical Affairs, Strategies and Timings

“Go-to-Market” in Pharma is defined as a tactical action plan, that outlines the needed steps to succeed in a...

Working with, Advocating for, and Empowering Patients

A version of this article was previously published on Pharmaphorum. In recent years, there has been a clear shift in...

Medical Affairs and Stakeholder Engagement in an Evolving Healthcare...

Due to unprecedented challenging situation and the current pandemic time, stakeholders needs are changing and these uncertain times are...

“Fake News” and Credibility in Medical Publishing

A version of this article was previously published on Pharmaphorum. Doubtlessly, one of the defining phrases of the 2010s is...

Top 10 Most Important Advisor Questions

Today, I would like to share the top 10 most important advisor questions that every brand team should keep in mind...

Optimizing Survivorship Care in Oncology

I have previously discussed a range of topics related to the diagnosis and treatment of cancer, including the use...

Navigating Emerging Markets – Opportunities and Challenges for Pharma

The pharmaceutical industry is quickly evolving; to stay relevant and competitive, companies need to stay on top of the...

Natalie Yeadon´s Newsletter




Secondary effects of COVID-19 on the healthcare system and...

A version of this article was previously published on Pharmaphorum. By now, your social media feeds are probably full...

Working with, Advocating for, and Empowering Patients

A version of this article was previously published on Pharmaphorum. In recent years, there has been a clear shift in...

“Fake News” and Credibility in Medical Publishing

A version of this article was previously published on Pharmaphorum. Doubtlessly, one of the defining phrases of the 2010s is...

Top 10 Most Important Advisor Questions

Today, I would like to share the top 10 most important advisor questions that every brand team should keep in mind...

Optimizing Survivorship Care in Oncology

I have previously discussed a range of topics related to the diagnosis and treatment of cancer, including the use...

Navigating Emerging Markets – Opportunities and Challenges for Pharma

The pharmaceutical industry is quickly evolving; to stay relevant and competitive, companies need to stay on top of the...

Tommaso Salanitri´s Newsletter




“Go-to-Market”: Medical Affairs, Strategies and Timings

“Go-to-Market” in Pharma is defined as a tactical action plan, that outlines the needed steps to succeed in a...

Medical Affairs and Stakeholder Engagement in an Evolving Healthcare...

Due to unprecedented challenging situation and the current pandemic time, stakeholders needs are changing and these uncertain times are...

EDITOR´S PICK




Comparative Analysis of COVID-19 Reveals a Cytokine Shower, Not...

MANHASSET, N.Y.--(BUSINESS WIRE)--Since coronavirus disease 2019 (COVID-19) emerged, researchers and doctors have suggested that the infection provokes a destructive...

Dr. Reddy’s and RDIF receive approval to conduct clinical...

HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) and Russian Direct Investment Fund (RDIF), Russia’s...

Genentech Announces Full FDA Approval for Venclexta Combinations for...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that...

Janssen Receives CHMP Positive Opinion for Expanded Use of...

BEERSE, Belgium--(BUSINESS WIRE)--The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the Committee for Medicinal Products for...

Hello Future: 2020 World Young Scientist Summit to Open...

WENZHOU, China--(BUSINESS WIRE)--2020 World Young Scientist Summit (http://www.wyss.org.cn) will be held in Wenzhou City of Zhejiang Province in Eastern...

Moderna Announces Initiation of Rolling Submission to Health Canada...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a...

LOOK WHO IS ON THE MOVE!




ONK Therapeutics Closes New Financing and Appoints Chris Nowers...

GALWAY, Ireland--(BUSINESS WIRE)--ONK Therapeutics Ltd, an innovative natural killer (NK) cell therapy company, today announced that it has raised...

AVEO Oncology Announces Appointment of David W. Crist as...

BOSTON--(BUSINESS WIRE)--AVEO Oncology (Nasdaq: AVEO) today announced the appointment of David Crist as Vice President of Sales. In this...

Nimbus Therapeutics Appoints Erin Cowhig as Chief People Officer

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nimbus Therapeutics, a biotechnology company designing breakthrough medicines through structure-based drug discovery and development, today announced the...

Inflection Biosciences Announces Appointment of Gregory I. Berk, MD,...

DUBLIN--(BUSINESS WIRE)--Inflection Biosciences Ltd, a company developing innovative therapeutics for the treatment of cancer, today announced the appointment of...

ViiV Healthcare receives positive CHMP opinion for long-acting regimen...

LONDON--(BUSINESS WIRE)--ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as...

Selexis Names Biopharmaceutical Executive Dirk Lange as New Chief...

GENEVA--(BUSINESS WIRE)--Selexis SA, a JSR Life Sciences Company, today announced the appointment of Dirk Lange to Chief Executive Officer...

INDUSTRY NEWS




Transgene: Acceptance of Late Breaking Abstract at Upcoming SITC...

STRASBOURG, France--(BUSINESS WIRE)--Regulatory News: Transgene (Paris:TNG) (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer,...

Ultimovacs Announces Updated Positive Results from Phase I Trial...

OSLO, Norway--(BUSINESS WIRE)--Ultimovacs ASA ("Ultimovacs", ticker ULTIMO), today announced five-year overall survival data from the Phase I trial evaluating...

Akron Biotech Signs Agreement With Synairgen plc to Supply...

BOCA RATON, Fla.--(BUSINESS WIRE)--Akron Biotechnology today announced it has signed an agreement with Synairgen plc (LSE: SNG) for the...

Genesis Therapeutics Enters AI-driven, Multi-Target Drug Discovery Partnership with...

BURLINGAME, Calif.--(BUSINESS WIRE)--Genesis Therapeutics, a privately-held company inventing and deploying state-of-the-art artificial intelligence (AI) techniques to augment drug discovery...

LabCorp Launches Quantitative Antibody Test to Assess Effectiveness of...

BURLINGTON, N.C.--(BUSINESS WIRE)--LabCorp (NYSE: LH), a leading global life sciences company that is focused on advancing health and guiding...

VelosBio Announces First Patient Dosed in Phase 2 Trial...

SAN DIEGO--(BUSINESS WIRE)--VelosBio Inc. (VelosBio), a clinical-stage biopharmaceutical company committed to developing first-in-class cancer therapies targeting receptor tyrosine kinase-like...

REGULATORY AFFAIRS




 Prestige Biopharma Receives Positive EMA Opinion on Orphan Designation...

SINGAPORE--(BUSINESS WIRE)--Prestige BioPharma Ltd. (hereinafter “Prestige BioPharma”) today announced that the European Medicines Agency (EMA) Orphan Drug Commission (COMP)...

Octapharma announces FDA approval of updated NUWIQ® Prescribing Information...

LACHEN, Switzerland--(BUSINESS WIRE)--Octapharma is pleased to announce that the U.S. Food and Drug Administration (FDA) has approved an updated...

Versantis Receives FDA Rare Pediatric Disease Designation for VS-01...

ZURICH, Switzerland--(BUSINESS WIRE)--Versantis AG, a clinical-stage company developing novel therapies for orphan liver diseases, today announced that the U.S....

Eurofins U.S. Clinical Diagnostics Network Receives EUA Approval of...

LUXEMBOURG--(BUSINESS WIRE)--Eurofins U.S. Clinical Diagnostics, announced that Clinical Enterprise Inc. has received an Emergency Use Authorization (EUA) from the...

U.S. Food and Drug Administration Accepts for Priority Review...

PRINCETON, N.J. & ALAMEDA, Calif.--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) and Exelixis, Inc. (NASDAQ: EXEL) today announced that the...

Genentech Announces Full FDA Approval for Venclexta Combinations for...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that...

MEDICAL DEVICES




SG Blocks and OSANG Healthcare Announce Managed Supply Agreement...

NEW YORK--(BUSINESS WIRE)--SG Blocks, Inc. (Nasdaq: SGBX) ("SG Blocks" or the "Company"), a leader in modular container-based structures and...

Veracyte Announces New Data Reinforcing Foundational Technology of Nasal...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc., (Nasdaq: VCYT) today announced that new data presented at the CHEST Annual Meeting...

Endologix Launches ALTO™ Abdominal Stent Graft System in Europe

IRVINE, Calif.--(BUSINESS WIRE)--Furthering its mission to transform the treatment of aortic disorders, Endologix LLC today announced the first implant...

STRAP Technologies Announces Groundbreaking Device to Aid the Visually...

AUSTIN, Texas--(BUSINESS WIRE)--STRAP Technologies announced today, on White Cane Safety Day in the United States, the creation of a...

Smiths Medical and bioAffinity Technologies Partner to Advance Non-Invasive...

SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, a privately held biotech company, and Smiths Medical, a leading global medical device manufacturer, today...

Exact Sciences Selects Veeva Vault Clinical Suite to Help...

PLEASANTON, Calif.--(BUSINESS WIRE)--Veeva Systems (NYSE: VEEV) today announced that Exact Sciences, a leading provider of cancer screening and diagnostic...

HOSPITAL NEWS




ONK Therapeutics Closes New Financing and Appoints Chris Nowers...

GALWAY, Ireland--(BUSINESS WIRE)--ONK Therapeutics Ltd, an innovative natural killer (NK) cell therapy company, today announced that it has raised...

Transgene: Acceptance of Late Breaking Abstract at Upcoming SITC...

STRASBOURG, France--(BUSINESS WIRE)--Regulatory News: Transgene (Paris:TNG) (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer,...

Akron Biotech Signs Agreement With Synairgen plc to Supply...

BOCA RATON, Fla.--(BUSINESS WIRE)--Akron Biotechnology today announced it has signed an agreement with Synairgen plc (LSE: SNG) for the...

Ultimovacs Announces Updated Positive Results from Phase I Trial...

OSLO, Norway--(BUSINESS WIRE)--Ultimovacs ASA ("Ultimovacs", ticker ULTIMO), today announced five-year overall survival data from the Phase I trial evaluating...

Genesis Therapeutics Enters AI-driven, Multi-Target Drug Discovery Partnership with...

BURLINGAME, Calif.--(BUSINESS WIRE)--Genesis Therapeutics, a privately-held company inventing and deploying state-of-the-art artificial intelligence (AI) techniques to augment drug discovery...

AVEO Oncology Announces Appointment of David W. Crist as...

BOSTON--(BUSINESS WIRE)--AVEO Oncology (Nasdaq: AVEO) today announced the appointment of David Crist as Vice President of Sales. In this...

BIOTECHNOLOGY




Confo Therapeutics Announces Selection of First Product Candidate and...

GHENT, Belgium--(BUSINESS WIRE)--Confo Therapeutics today announced the selection of its first preclinical drug candidate, CFTX-1554, a compound designed to...

Transgene and BioInvent to Present Data on Oncolytic Virus...

STRASBOURG, France & LUND, Sweden--(BUSINESS WIRE)--Regulatory News: Transgene (Paris:TNG) (Euronext Paris: TNG), a biotech company that designs and develops virus-based...

BryoLogyx Announces Completion of World’s First GMP Synthesis of...

DANVILLE, Calif.--(BUSINESS WIRE)--BryoLogyx, Inc., today announced that it has completed the synthesis of bryostatin-1 molecule, pursuant to FDA’s Good...

Goldfinch Bio Announces Upcoming Presentation of Phase 1 Clinical...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Goldfinch Bio, a clinical stage biotechnology company focused on discovering and developing precision medicines for the treatment...

Twist Bioscience and Neogene Announce Broad Strategic Partnership for...

SOUTH SAN FRANCISCO, Calif. & AMSTERDAM & NEW YORK--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to...

Finch Therapeutics to Present Data from its Positive PRISM3...

SOMERVILLE, Mass.--(BUSINESS WIRE)--Finch Therapeutics Group, Inc. (“Finch”), a clinical-stage microbiome drug development company, announced today that data from its...